How the other half lives, the amino-terminal domain of the retinoblastoma tumor suppressor protein
✍ Scribed by David W. Goodrich
- Publisher
- John Wiley and Sons
- Year
- 2003
- Tongue
- English
- Weight
- 211 KB
- Volume
- 197
- Category
- Article
- ISSN
- 0021-9541
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
The retinoblastoma tumor suppressor gene (RB1) is currently the only known gene whose mutation is necessary and sufficient for the development of a human cancer. Mutation or deregulation of RB1 is observed so frequently in other tumor types that compromising RB1 function may be a prerequisite for malignant transformation. Identifying the molecular mechanisms that provide the basis for RB1‐mediated tumor suppression has become an important goal in the quest to understand and treat cancer. The lion's share of research on these mechanisms has focused on the carboxy‐terminal half of the RB1 encoded protein (pRB). This focus is with good reason since this part of the protein, now called the “large pocket,” is required for most of its known activities identified in vitro and in vivo. Large pocket mediated mechanisms alone, however, cannot account for all observed properties of pRB. The thesis presented here is that the relatively uncharacterized amino‐terminal half of the protein makes important contributions to pRB‐mediated tumor suppression. The goals of this review are to summarize evidence indicating that an amino‐terminal structural domain is important for pRB function and to suggest a general hypothesis as to how this domain can be integrated with current models of pRB function. J. Cell. Physiol. 197: 169–180, 2003© 2003 Wiley‐Liss, Inc.